CRISPR Technology Global Market Report 2024

Description

CRISPR is a gene-editing technology enabling researchers to modify DNA sequences, effectively altering gene function and genetic information.

The primary product categories in CRISPR technology include design tools, plasmids and vectors, CAS9 and G-RNA components, and delivery systems. CRISPR-Cas9 is an innovative tool allowing scientists to edit specific genome sections by adding, removing, or altering DNA sequences. Applications encompass genome editing, genetic engineering, agricultural biotechnology, among others, and find utility across various sectors including industrial biotech, biological and agricultural research, therapeutics, and drug discovery.

The CRISPR technology market research report is one of a series of new reports from The Business Research Company that provides CRISPR technology market statistics, including CRISPR technology industry global market size, regional shares, competitors with a CRISPR technology market share, detailed CRISPR technology market segments, market trends and opportunities, and any further data you may need to thrive in the CRISPR technology industry. This CRISPR technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The crispr technology market size has grown exponentially in recent years. It will grow from $1.64 billion in 2023 to $2.04 billion in 2024 at a compound annual growth rate (CAGR) of 24.1%. Historical growth can be attributed to the increase in funding and a rise in pharmaceutical research and development (R&D) expenditure.

The crispr technology market size is expected to see exponential growth in the next few years. It will grow to $4.65 billion in 2028 at a compound annual growth rate (CAGR) of 22.9%. The anticipated growth hinges on increased demand for gene therapeutics, advancements in genome editing technology, rising needs in drug discovery, expanded applications of CRISPR in diagnostics and agriculture, coupled with a surge in CRISPR technology adoption. Major trends involve innovative technology development, enhanced CRISPR for drug discovery, AI-assisted precise gene editing, investments in accuracy-improving approaches such as idmseq, collaborations, and licensing agreements.

The adoption of CRISPR technology as a diagnostic tool is poised to elevate the market's trajectory. Notably, the Sherlock CRISPR SARS-CoV-2 kit stands out as the inaugural diagnostic kit employing CRISPR technology for infectious diseases, particularly COVID-19. In February 2021, the FDA granted emergency use authorization to Sherlock BioSciences Inc.'s CRISPR-based SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing) diagnostic test. This kit exhibits high specificity and sensitivity, targeting RNA or DNA sequences of the SARS-CoV-2 virus with precision from various specimens. Its reliability in avoiding false negatives or positives positions CRISPR technology as a pivotal player in infectious disease diagnosis, fostering a surge in demand for CRISPR products and services.

The CRISPR technology market is set to witness substantial growth propelled by the escalating number of ongoing clinical trials. Clinical trials, pivotal in assessing the safety and efficacy of new medical interventions, are increasingly leveraging CRISPR technology as a potent gene-editing tool. Various trials, spanning cancer treatment, blood disorders, inherited eye diseases, and infectious diseases, underscore CRISPR's versatility and potential. Notably, as of February 2023, the World Health Organization reports a significant uptick in clinical trials in the US, reaching 168,520 in 2022-an increase of 9,901 trials. This surge in clinical trials underscores the burgeoning role of CRISPR technology in advancing medical research and treatment methodologies.

Key players in the CRISPR technology market are strategically focusing on the development of innovative products, specifically tailored CRISPR solutions, to enhance their service offerings. Dedicated CRISPR products refer to specialized tools and reagents designed exclusively for CRISPR gene editing applications. Illustratively, QIAGEN NV, a Germany-based leader in sample and assay technologies, introduced the QIAprep & CRISPR Kit and CRISPR Q-Primer Solutions in June 2021. These products offer an all-in-one, sensitive method for detecting knock-ins resulting from small insertions during gene editing and knockouts generated from guide RNA (gRNA). The incorporation of the Sanger DNA sequencing method, along with downstream PCR detection, coupled with liquid-based sample preparation, distinguishes these kits and solutions.

In March 2021, Integrated DNA Technologies (IDT), a prominent genomics solutions provider based in the United States, successfully acquired Swift Biosciences. This strategic acquisition is aimed at capitalizing on Swift Biosciences' expertise in academic and clinical research related to Next-Generation Sequencing (NGS). Swift Biosciences, based in the U.S., is recognized for its contributions to the development of genomics kits specifically designed for preparing NGS libraries. This strategic move reinforces the commitment of major companies to expanding their product portfolios and staying at the forefront of technological advancements in the CRISPR technology market.

Major companies operating in the crispr technology market report are Crispr Therapeutics, Thermo Fisher Scientific, Intellia Therapeutics, Horizon Discovery, Synthego Corporation, Integrated Dna Technology (Danaher), Editas Medicine, GenScript, Agilent Technologies, New England Biolabs, CSIR-Institute of Genomics & Integrative Biology (IGIB), Strand Life Sciences Pvt. Ltd., Bio Palette Co. Ltd., CSL Limited, C4U Co. Ltd., BGI Group, Churchi Genome Engineering and Therapeutic Research Center., Beam Therapeutics Inc., Eurofins Genomics India, Setsurotech Co. Ltd., Merck Japan, Institut Pasteur, CureVac, Cellectis, BiovelocITA S.r.l., Evotec A.G., SNIPR Biome, Oxford Genetics, ERS Genomics, Alia Therapeutics, Solvo, BioTalentum, Rosneft, BIOCAD, BioVendor, Research & Diagnostic Products, Contipro, Lonza Biotec, Sotio, Selvita, BioVentures Institute Ltd., Sigma-Aldrich, Poseida Therapeutics, NanoCellect Biomedical, Sherlock Biosciences, Repare Therapeutics, Inscripta Inc., Santa Cruz Biotechnology, Caribou Biosciences Inc., Egenesis Inc., Homology Medicines, System Biosciences, Takara Bio USA Inc., Inari Agriculture Inc., Precision BioSciences, Cell Microsystems Inc., GeneCopoeia Inc., Horizon Discovery Group, Merck KGaA, Origene Technologies Inc., Pluristem Therapeutics Inc.

North America was the largest region in the CRISPR technology market in 2023. Western Europe was the second largest region in the global CRISPR technology market. The regions covered in the crispr technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the crispr technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The CRISPR technology market includes revenue earned by CRISPR Screening Libraries, CRISPR Positive Controls, CRISPR Negative Controls, and Gene-specific Knockout Kits. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

CRISPR Technology Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on CRISPR technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for CRISPR technology? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The CRISPR technology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Product Type: Design Tools; Plasmid And Vector; Cas9 And G-RNA; Delivery System Products
2) By Application: Biomedical; Agriculture; Diagnostics; Other Applications
3) By End-User: Academic Research Organizations; Biopharmaceutical Companies; Agricultural Biotechnology Companies; Contract Research Organizations (CROs)
Companies Mentioned: Crispr Therapeutics; Thermo Fisher Scientific; Intellia Therapeutics; Horizon Discovery; Synthego Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r14395

1. Executive Summary

2. CRISPR Technology Market Characteristics

3. CRISPR Technology Market Trends And Strategies

4. CRISPR Technology Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global CRISPR Technology Market Size and Growth

5.1. Global CRISPR Technology Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global CRISPR Technology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global CRISPR Technology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. CRISPR Technology Market Segmentation

6.1. Global CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Design Tools
Plasmid And Vector
Cas9 And G-RNA
Delivery System Products
6.2. Global CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Genome Editing/ Genetic Engineering
Genetically Modified Organisms
Agricultural Biotechnology
Other Applications
6.3. Global CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Industrial Biotech
Biological Research
Agricultural Research
Therapeutics And Drug Discovery

7. CRISPR Technology Market Regional And Country Analysis

7.1. Global CRISPR Technology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global CRISPR Technology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific CRISPR Technology Market

8.1. Asia-Pacific CRISPR Technology Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China CRISPR Technology Market

9.1. China CRISPR Technology Market Overview
9.2. China CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India CRISPR Technology Market

10.1. India CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan CRISPR Technology Market

11.1. Japan CRISPR Technology Market Overview
11.2. Japan CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia CRISPR Technology Market

12.1. Australia CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia CRISPR Technology Market

13.1. Indonesia CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea CRISPR Technology Market

14.1. South Korea CRISPR Technology Market Overview
14.2. South Korea CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe CRISPR Technology Market

15.1. Western Europe CRISPR Technology Market Overview
15.2. Western Europe CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK CRISPR Technology Market

16.1. UK CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany CRISPR Technology Market

17.1. Germany CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France CRISPR Technology Market

18.1. France CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy CRISPR Technology Market

19.1. Italy CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain CRISPR Technology Market

20.1. Spain CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe CRISPR Technology Market

21.1. Eastern Europe CRISPR Technology Market Overview
21.2. Eastern Europe CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia CRISPR Technology Market

22.1. Russia CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America CRISPR Technology Market

23.1. North America CRISPR Technology Market Overview
23.2. North America CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA CRISPR Technology Market

24.1. USA CRISPR Technology Market Overview
24.2. USA CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada CRISPR Technology Market

25.1. Canada CRISPR Technology Market Overview
25.2. Canada CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America CRISPR Technology Market

26.1. South America CRISPR Technology Market Overview
26.2. South America CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil CRISPR Technology Market

27.1. Brazil CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East CRISPR Technology Market

28.1. Middle East CRISPR Technology Market Overview
28.2. Middle East CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa CRISPR Technology Market

29.1. Africa CRISPR Technology Market Overview
29.2. Africa CRISPR Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa CRISPR Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. CRISPR Technology Market Competitive Landscape And Company Profiles

30.1. CRISPR Technology Market Competitive Landscape
30.2. CRISPR Technology Market Company Profiles
- 30.2.1. Crispr Therapeutics
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Thermo Fisher Scientific
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Intellia Therapeutics
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Horizon Discovery
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Synthego Corporation
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. CRISPR Technology Market Other Major And Innovative Companies

31.1. Integrated DNA Technology (Danaher)
31.2. Editas Medicine
31.3. GenScript
31.4. Agilent Technologies
31.5. New England Biolabs
31.6. CSIR-Institute of Genomics & Integrative Biology (IGIB)
31.7. Strand Life Sciences Pvt. Ltd.
31.8. Bio Palette Co. Ltd.
31.9. CSL Limited
31.10. C4U Co. Ltd.
31.11. BGI Group
31.12. Churchi Genome Engineering and Therapeutic Research Center.
31.13. Beam Therapeutics Inc.
31.14. Eurofins Genomics India
31.15. Setsurotech Co. Ltd

32. Global CRISPR Technology Market Competitive Benchmarking

33. Global CRISPR Technology Market Competitive Dashboard

34. Key Mergers And Acquisitions In The CRISPR Technology Market

35. CRISPR Technology Market Future Outlook and Potential Analysis

35.1 CRISPR Technology Market In 2028 - Countries Offering Most New Opportunities
35.2 CRISPR Technology Market In 2028 - Segments Offering Most New Opportunities
35.3 CRISPR Technology Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer